Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15387)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 15, 2015 (publication date) through Jul 5, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yamaguchi H, Kitayama J, Ishigami H, Kazama S, Nozawa H, Kawai K, Hata K, Kiyomatsu T, Tanaka T, Tanaka J, Nishikawa T, Otani K, Yasuda K, Ishihara S, Sunami E, Watanabe T. Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes. World J Gastrointest Oncol 2015; 7(11): 285-291 [PMID: 26600928 DOI: 10.4251/wjgo.v7.i11.285] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v7/i11/285.htm |
| Number | Citing Articles |
| 1 |
Manuela Robella, Michele De Simone, Paola Berchialla, Monica Argenziano, Alice Borsano, Shoeb Ansari, Ornella Abollino, Eleonora Ficiarà, Armando Cinquegrana, Roberta Cavalli, Marco Vaira. A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Carcinomatosis. Cancers 2021; 13(5): 1060 doi: 10.3390/cancers13051060
|
| 2 |
Hideyuki Ohzawa, Yuki Kimura, Akira Saito, Hironori Yamaguchi, Hideyo Miyato, Yasunaru Sakuma, Hisanaga Horie, Yoshinori Hosoya, Alan Kawarai Lefor, Naohiro Sata, Joji Kitayama. Ratios of miRNAs in Peritoneal Exosomes are Useful Biomarkers to Predict Tumor Response to Intraperitoneal Chemotherapy in Patients with Peritoneal Metastases from Gastric Cancer. Annals of Surgical Oncology 2020; 27(13): 5057 doi: 10.1245/s10434-020-09007-2
|
| 3 |
Roman Yarema, Мyron Оhorchak, Petro Hyrya, Yuriy Kovalchuk, Victor Safiyan, Ivan Karelin, Severyn Ferneza, Markiyan Fetsych, Myron Matusyak, Yuriy Oliynyk, Тaras Fetsych. Gastric cancer with peritoneal metastases: Efficiency of standard treatment methods. World Journal of Gastrointestinal Oncology 2020; 12(5): 569-581 doi: 10.4251/wjgo.v12.i5.569
|
| 4 |
Amir Parray, Vikas Gupta, Vikram A. Chaudhari, Shailesh V. Shrikhande, Manish S. Bhandare. Role of intraperitoneal chemotherapy in gastric cancer. Surgery in Practice and Science 2021; 4: 100025 doi: 10.1016/j.sipas.2020.100025
|
| 5 |
Akira Saito, Joji Kitayama, Ryozo Nagai, Kenichi Aizawa. Anatomical Targeting of Anticancer Drugs to Solid Tumors Using Specific Administration Routes: Review. Pharmaceutics 2023; 15(6): 1664 doi: 10.3390/pharmaceutics15061664
|
| 6 |
Pralhad Wangikar, M. V. S. Sandhya, Pradhnya Choudhari. Exploring Drug Delivery to the Peritoneum. 2023; : 217 doi: 10.1007/978-3-031-31694-4_10
|
| 7 |
Brian Badgwell, Naruhiko Ikoma, Mariela Blum, Xuemei Wang, Jeannelyn Estrella, Xiaoqian Liu, Jitesh Kawedia, Jenny Li, Paul Mansfield, Jaffer Ajani. Phase 1 trial of intraperitoneal paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology. Cancer 2025; 131(1) doi: 10.1002/cncr.35566
|
| 8 |
Daisuke Kobayashi, Yasuhiro Kodera. Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis. Gastric Cancer 2017; 20(S1): 111 doi: 10.1007/s10120-016-0662-9
|
| 9 |
Hanqing Qian, Keyang Qian, Juan Cai, Yan Yang, Lijing Zhu, Baorui Liu. Therapy for Gastric Cancer with Peritoneal Metastasis Using Injectable Albumin Hydrogel Hybridized with Paclitaxel-Loaded Red Blood Cell Membrane Nanoparticles. ACS Biomaterials Science & Engineering 2019; 5(2): 1100 doi: 10.1021/acsbiomaterials.8b01557
|
| 10 |
Beatrice J. Sun, Byrne Lee. Review of Regional Therapies for Gastric Cancer with Peritoneal Metastases. Cancers 2022; 14(3): 570 doi: 10.3390/cancers14030570
|
| 11 |
Maheswari Senthil, Farshid Dayyani. Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis - STOPGAP trial. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10680-1
|
| 12 |
Tomoko Tachibana, Yukie Yoshii, Hiroki Matsumoto, Ming-Rong Zhang, Kotaro Nagatsu, Fukiko Hihara, Chika Igarashi, Aya Sugyo, Atsushi B. Tsuji, Tatsuya Higashi. Efficacy of vorinostat-sensitized intraperitoneal radioimmunotherapy with 64Cu-labeled cetuximab against peritoneal dissemination of gastric cancer in a mouse model. Journal of Cancer Research and Therapeutics 2022; 18(4): 907 doi: 10.4103/jcrt.JCRT_124_20
|
| 13 |
Minlu Huang, Xinjie Ma, Hongpeng Shi, Lei Hu, Zhiyuan Fan, Li Pang, Fan Zhu, Xiao Yang, Wei Xu, Binya Liu, Zhenggang Zhu, Chen Li. FAM83D, a microtubule-associated protein, promotes tumor growth and progression of human gastric cancer. Oncotarget 2017; 8(43): 74479 doi: 10.18632/oncotarget.20157
|
| 14 |
Y. Hao, Y. Liu, H. Ishibashi, S. Wakama, E. Nishino, Y. Yonemura. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis. European Journal of Surgical Oncology 2019; 45(8): 1493 doi: 10.1016/j.ejso.2019.03.011
|
| 15 |
Amy Y. Li, Shaina Sedighim, Fatemeh Tajik, Aaqil M. Khan, Vinodh K. Radhakrishnan, Farshid Dayyani, Maheswari Senthil. Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal Disease. Journal of Gastrointestinal Cancer 2024; 55(2): 534 doi: 10.1007/s12029-023-00994-5
|
| 16 |
Lin Hu, Hong-Lang Li, Wei-Feng Li, Jun-Min Chen, Jian-Tao Yang, Jun-Jing Gu, Lin Xin. Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma. World Journal of Gastroenterology 2017; 23(20): 3721-3729 doi: 10.3748/wjg.v23.i20.3721
|
| 17 |
Zhen Wang, Jun-qiang Chen, Jin-lu Liu, Lei Tian. Issues on peritoneal metastasis of gastric cancer: an update. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1761-y
|
| 18 |
Koki Nakanishi, Mitsuro Kanda, Shinichi Umeda, Chie Tanaka, Daisuke Kobayashi, Masamichi Hayashi, Suguru Yamada, Yasuhiro Kodera. The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer. Gastric Cancer 2019; 22(6): 1143 doi: 10.1007/s10120-019-00967-3
|
| 19 |
Fatemeh Tajik, Belain Eyob, Aaqil M. Khan, Vinodh Kumar Radhakrishnan, Maheswari Senthil. Iterative Intraperitoneal Chemotherapy in Gastric Cancer Peritoneal Carcinomatosis. Cancers 2025; 17(2): 289 doi: 10.3390/cancers17020289
|
| 20 |
Mitsuro Kanda, Dai Shimizu, Haruyoshi Tanaka, Chie Tanaka, Daisuke Kobayashi, Masamichi Hayashi, Naoki Iwata, Yukiko Niwa, Suguru Yamada, Tsutomu Fujii, Hiroyuki Sugimoto, Kenta Murotani, Michitaka Fujiwara, Yasuhiro Kodera. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer. Annals of Surgery 2018; 267(3): 495 doi: 10.1097/SLA.0000000000002096
|
| 21 |
Manuela Robella, Marco Vaira, Monica Argenziano, Rita Spagnolo, Roberta Cavalli, Alice Borsano, Sergio Gentilli, Michele De Simone. Exploring the Use of Pegylated Liposomal Doxorubicin (Caelyx®) as Pressurized Intraperitoneal Aerosol Chemotherapy. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00669
|
| 22 |
Maheswari Senthil, Farshid Dayyani. Role of Iterative Normothermic Intraperitoneal Paclitaxel Combined with Systemic Chemotherapy in the Management of Gastric Peritoneal Carcinomatosis. Annals of Surgical Oncology 2024; 31(2): 694 doi: 10.1245/s10434-023-14258-w
|
| 23 |
Shunsuke Akagi, Hidenori Ando, Kenji Fujita, Taro Shimizu, Yu Ishima, Kenji Tajima, Tokuo Matsushima, Takatomo Kusano, Tatsuhiro Ishida. Therapeutic efficacy of a paclitaxel-loaded nanofibrillated bacterial cellulose (PTX/NFBC) formulation in a peritoneally disseminated gastric cancer xenograft model. International Journal of Biological Macromolecules 2021; 174: 494 doi: 10.1016/j.ijbiomac.2021.01.201
|
| 24 |
Manuela Robella, Paola Berchialla, Alice Borsano, Armando Cinquegrana, Alba Ilari Civit, Michele De Simone, Marco Vaira. Study Protocol: Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Metastases. International Journal of Environmental Research and Public Health 2021; 18(11): 5656 doi: 10.3390/ijerph18115656
|
| 25 |
Xin Zhang, Hejing Huang, Dejun Yang, Peng Wang, Xin Huang, Zunqi Hu, Yu Zhang, Ronglin Yan, Zhenxin Zhu, Qingping Cai. Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis. Technology in Cancer Research & Treatment 2021; 20 doi: 10.1177/15330338211036310
|
| 26 |
Hironori Yamaguchi, Yumiko Satoh, Hironori Ishigami, Makiko Kurihara, Yutaka Yatomi, Joji Kitayama. Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis. Annals of Surgical Oncology 2017; 24(11): 3345 doi: 10.1245/s10434-017-5997-x
|